Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial

Toni K. Choueiri, Konstantin Penkov, Hiroji Uemura, Matthew T. Campbell, Sumanta K. Pal, Christian Kollmannsberger, J.L. Lee, B. Venugopal, A.J.M. van den Eertwegh, Sylvie Négrier, Howard Gurney, Laurence Albigès, Raanan Berger, John B.A.G. Haanen, Víctor Manuel Oyervides-Juárez, Brian I. Rini, James Larkin, Franco Nolè, M. Schmidinger, M.B. Atkins, Yoshihiko Tomita, B. Ellers-Lenz, Jason Hoffman, R. Sandner, J. Wang, A. di Pietro, R.J. Motzer